Andrew Coop, PhD

Titles

Professor of Pharmaceutical Sciences

Associate Dean for Academic Affairs

Interim Associate Dean for Graduate Programs

School Affiliation

School of Pharmacy

Specialties

  • Drug Design

About

Dr. Coop received his PhD from the University of Bristol (England) in the area of chemistry of drugs of abuse, followed by a Fogarty postdoctoral fellowship at the National Institutes of Health (NIH). He has been a School of Pharmacy faculty member since 1999, serving as a department chair from 2007 to 2015. His NIH-funded research focuses on the design and synthesis of new opioid analgesics with reduced tolerance and the development of novel antidepressants. He has developed the compound UMB 425 preclinically as an opioid analgesic with attenuated tolerance development. He has published 130 manuscripts and was the recipient of the 2003 Joseph Cochin Young Investigator Award from the College on Problems of Drug Dependence (CPDD). In 2014, he was named a fellow of CPDD and presented CPDD’s President’s Lecture. In 2014, he received the inaugural Dr. James E. Wynn Memorial Award from the American Association of Colleges of Pharmacy’s Chemistry Section. As associate dean for academic affairs, Dr. Coop oversees the school’s educational programs including assessment and accreditation, instructional design, electronic learning resources and training, pathways and dual degrees, and academic scheduling.

Read a longer bio.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged: The Future of Health Care   Caring for the Human Condition   Research and Innovation  

This information was last updated January 9, 2024.